Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid …
S Oikawa, M Yokoyama, H Origasa, M Matsuzaki… - Atherosclerosis, 2009 - Elsevier
BACKGROUND: JELIS was a large-scale clinical trial that investigated the effects of
eicosapentaenoic acid (EPA) on coronary artery disease (CAD). In this paper, the data of
patients registered in JELIS were analysed to compare the incidence of CAD between
patients with impaired glucose metabolism (IGM) and normoglycemic (NG) patients. The
effect of EPA on the incidence of CAD in patients with IGM was also assessed. METHODS:
The 18,645 hypercholesterolemic patients registered in JELIS were divided into two groups …
eicosapentaenoic acid (EPA) on coronary artery disease (CAD). In this paper, the data of
patients registered in JELIS were analysed to compare the incidence of CAD between
patients with impaired glucose metabolism (IGM) and normoglycemic (NG) patients. The
effect of EPA on the incidence of CAD in patients with IGM was also assessed. METHODS:
The 18,645 hypercholesterolemic patients registered in JELIS were divided into two groups …
